A carregar...
Natalizumab in the treatment of multiple sclerosis
Natalizumab is a monoclonal antibody, representing a new class of medication for treating relapsing multiple sclerosis (MS). Conventional treatments include interferons, glatiramer acetate and chemotherapies such as mitoxantrone and cyclophosphamide. These therapies offer only modest clinical benefi...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2724189/ https://ncbi.nlm.nih.gov/pubmed/19707275 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|